Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

M. Cuffe, R. Califf, K. Adams, R. Benza, R. Bourge, W. Colucci, B. Massie, C. O'Connor, I. Pina, R. Quigg, M. Silver, Mihai Gheorghiade, Marcus G. Hennersdorf

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)154-155
Number of pages2
JournalEvidence-based Cardiovascular Medicine
Volume6
Issue number4
DOIs
StatePublished - Dec 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cuffe, M., Califf, R., Adams, K., Benza, R., Bourge, R., Colucci, W., Massie, B., O'Connor, C., Pina, I., Quigg, R., Silver, M., Gheorghiade, M., & Hennersdorf, M. G. (2002). Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure. Evidence-based Cardiovascular Medicine, 6(4), 154-155. https://doi.org/10.1054/ebcm.2002.0490